Table 1 Reader’s interpretation data in relation to tumor response

Mean tumor size based on pre-procedural RECIST

77.92

(CI = 68.58–87.26)

80.15

(CI = 70.36–89.94)

77.66

(CI = 67.89–87.43)

Mean tumor size based on post-procedural RECIST

74.12

(CI = 64.20-84.03)

74.62

(CI = 64.40-84.85)

72.52

(CI = 62.12–82.93)

Mean tumor size based on pre-procedural mRECIST

70.62

(CI = 62.05–79.18)

73.14

(CI = 63.83–82.45)

67.42

(CI = 58.90-75.95)

Mean tumor size based on post-procedural mRECIST

44.60

(CI = 36.14–53.06)

42.22

(CI = 33.02–51.41)

42.23

(CI = 33.73–50.73)

RECIST treatment response category

2: partial response

9 (9.38%)

10 (10.42%)

11 (11.58%)

3: progressive disease

77 (80.21%)

80 (83.33%)

76 (80.00%)

4: stable disease

10 (10.42%)

6 (6.25%)

8 (8.42%)

mRECIST treatment response category

1: complete response

21 (21.88%)

26 (27.08%)

14 (14.74%)

2: partial response

40 (41.67%)

41 (42.71%)

45 (47.36%)

3: progressive disease

29 (30.21%)

25 (26.04%)

32 (33.68%)

4: stable disease

6 (6.25%)

4 (4.17%)

4 (4.21%)